Congratulations Maya K. Khalil, MD Aakash Desai, MD, MPH 💪on leading underrepresented population accruals on SWOG Cancer Research Network #LUNG-PRAGMATICA!! The Hope Foundation for Cancer Research !! Need representation of other pts as well! Dr. Nagla Abdel Karim Anne Chiang Krishna Soujanya Gunturu MD Jhanelle Gray MD David Gandara

Congratulations to Dr. Rustgi for being awarded the AACR Daniel Von Hoffman award for mentorship in education! Extremely well deserved! Herbert Irving Comprehensive Cancer Center AACR

Looking forward to super ⭐️ medical oncology fellow Lawrence Wu presenting our work today on molecular profiling of early onset esophagogastric cancer from real world NGS data #AACR24

OK, this one is really meaningful for our whole team. Our preclinical paper on pan-RAS inhibition in pancreatic cancer is now online nature. Led by OliveLab student Ula Waśko and Revolution Medicines colleagues JingJing Jiang and Mallika Singh. nature.com/articles/s4158…

Mechanistically, RMC-7977 is a molecular glue. It directly binds Cyclophilin A, a large, abundant chaperone protein, causing it to selectively bind to KRAS, HRAS, and NRAS. The related investigational agent RMC-6236 is in Phase 1 and 2 clinical trials. media.giphy.com/media/v1.Y2lkP…

Great biology - and the ph1 trial is open Herbert Irving Comprehensive Cancer Center w/ my colleague who first reported WRN-MSI synthetic lethality, Edmond Chan

So excited to share that my IIT - Gilteritinib for the Treatment of ALK NSCLC - is finally open to accrual! clinicaltrials.gov/study/NCT06225… Grateful to ALK Positive and LUNGevity Foundation for their support. Here's to making a difference for patients with ALK+ NSCLC. U-M Rogel Cancer Center

Thank you to my mentors and Herbert Irving Comprehensive Cancer Center Test Account NCI CTEP Clinical Research for pushing this #ETCTN trial forward for #sarcomas #rarediseases Huge thanks to Conquer Cancer, the ASCO Foundation for supporting our research. Excited to share more at #ASCO2024. Find me 6/1: 1:30-4:30PM Hall A Poster #452!

Tremendous oral presentation from Michael May at ASCO with co-first author Margaux on the discrepancy between patients eligible for and patients who benefit from KRASi in NSCLC! Herbert Irving Comprehensive Cancer Center #ASCO24

Congratulations to my ⭐️⭐️ co-fellow and Conquer Cancer, the ASCO Foundation Merit and YIA recipient Michael May on an excellent oral presentation at #ASCO2024! We are SO proud of you and we look forward to watch your rising trajectory! Herbert Irving Comprehensive Cancer Center NewYork-Presbyterian

Eight Columbia oncological physicians, scientists, and trainees have been awarded Conquer Cancer, the ASCO Foundation grants/awards to recognize and advance their impact on cancer research- Congratulations to these awardees, recognized at #ASCO24 !

🤩Excited to be selected for the 2024 ASCO Leadership Development Program. Overjoyed to join a group of motived oncologists for essential leadership skills training. The 2025 application is open soon. Completed training 2015-2020? You are eligible! society.asco.org/career-develop…

#JCOPO Editorial Fellows share insights into publication trends and future directions for JCO Precision Oncology ➡️ brnw.ch/21wKKen

Congratulations to the 2024 Precision Medicine Joint Pilot awardees! HICCC's research team, led by Carla Concepcion Crisol (PI) and Benjamin Herzberg will focus on evaluating SMARCA4-mutant non-small cell lung cancer.

AACR Project GENIE® held its Summer Summit this week in Philadelphia. Chaired by Brian Henick and Marilyn Li, the summit celebrated the 10th anniversary of the think tank convened by AACR Past-President Charles Sawyers that launched this vital initiative. #AACRGENIE Brian Henick

Grateful for the opportunity to develop this exciting program with Dr. Marilyn Li and the #AACRGENIE team! Herbert Irving Comprehensive Cancer Center

A Closer Look at the Innovative Pragmatica-Lung Trial SWOG Cancer Research Network S2302 chair Karen Reckamp, MD, MS interviewed on streamlined phase 3 trial in #NSCLC w broader eligibility & lower site burden. Rewriting how we do oncology #ClinicalTrials. Lung-MAP NCI CTEP Clinical Research medpagetoday.com/meetingcoverag…

The Lung-MAP master protocol has screened more than 5,000 patients with advanced #NSCLC. Data from these patients are driving #research to further our understanding of common #lungcancer mutations and to discover future treatment targets. Learn more: lung-map.org